Prior Auth Required

10411 - trial. Lancet. 2023;402( ):1449-1458. doi:10.1016/ -6736(23) -0

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicetrial. Lancet. 2023;402( ):1449-1458. doi:10.1016/ -6736(23) -0
Procedure / Service Description

Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) - 7 Khanani AM, Patel SS, Staurenghi G, et al. Efficacy and safety of avacincaptad pegol in patients with 10/2023 11/2025 geographic atrophy (GATHER2): 12-month results from a randomized, double-masked, phase 3 trial. Lancet. 2023;402(10411):1449-1458. doi:10.1016/S0140-6736(23)01583-0 CAPITAL DISTRICT PHYSICIANS’ HEALTH PLAN, INC. CAPITAL DISTRICT PHYSICIANS’ HEALTH CARE NETWORK, INC.

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.